Auckland-based lawyer, Lex Henry, has been appointed chairman of the Researched Medicines Industry (RMI).
A Special Counsel with Auckland law firm Minter Ellison Rudd Watts, Mr Henry currently chairs merchant bank Cranleigh,
is a Director of Ngai Tahu Properties and health software company MedTech, and a member of the Auckland University of
Technology Council and AUT Millennium Institute.
The Deputy Chair of the TransTasman Business Circle, and a Trustee of the Christchurch Arts Festival and the Asia NZ
Foundation, until recently Mr Henry was a Landcorp director and the Deputy Chairman of OnTrack (KiwiRail).
RMI Chief Executive Officer, Denise Wood, said Mr Henry also came to the RMI with a background as a director of an
English bank and two Wall Street investment banks, and had served as a New Zealand diplomat covering ASEAN.
His extensive national and international business experience and broad engagement within New Zealand’s public and
private sectors, was a positive fit with opportunities and challenges currently facing the country’s health arena, Ms
“His breadth of experience will be critical in further enabling the RMI to meet its vision of ensuring New Zealand
patients enjoy equitable access to high quality, innovative and cost effective medicines available internationally,” Ms
Mr Henry will replace Dr Pippa MacKay who resigned in October to focus on her Christchurch medical practice following
five years as the RMI chair.